{"id":"W4389280307","doi":"10.1016/j.annonc.2023.10.591","title":"512MO FLAURA2: Safety and CNS outcomes of first-line (1L) osimertinib (osi) ± chemotherapy (CTx) in EGFRm advanced NSCLC","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"AstraZeneca","keywords":"Medicine; Osimertinib; Chemotherapy; Oncology; Internal medicine; Adenocarcinoma; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004509515,0.0002158226,0.0005581338,0.0001976422,0.0001918885,0.00065151,0.0002881363,0.0004225584,0.003448997],"category_scores_gemma":[0.0007482553,0.0001105822,0.0005795139,0.0001939467,0.0002063017,0.0004331969,0.0001773319,0.00109234,0.0005663891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009645044,"about_ca_system_score_gemma":0.0006827644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001867758,"about_ca_topic_score_gemma":0.005368715,"domain_scores_codex":[0.9998172,0.0000514278,0.00001133604,0.00003441817,0.00003832191,0.00004723251],"domain_scores_gemma":[0.9997187,0.00005430432,0.00009675559,0.00002161437,0.00002698114,0.00008168371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1611596,0.006650341,0.1535927,0.0009168529,0.002640649,0.0005955434,0.0001835848,0.003386752,0.04143551,0.0007774042,0.01474109,0.61392],"study_design_scores_gemma":[0.03193288,0.1725848,0.7065014,0.0004716124,0.004980656,0.005597009,0.0004748976,0.01175929,0.03149099,0.001729363,0.03230242,0.0001746751],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931924,0.002907908,0.00008399998,0.0003782352,0.00004964595,0.00003102074,0.0005606933,0.00004698215,0.002749231],"genre_scores_gemma":[0.9965507,0.0009242089,0.0000805879,0.0002697502,0.00006217274,0.00002739398,0.0007798734,0.00001224368,0.001293103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003448997,"threshold_uncertainty_score":0.01153803,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05022058498647386,"score_gpt":0.4341389020565032,"score_spread":0.3839183170700294,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}